Cargando…

Triggering Immune System With Nanomaterials for Cancer Immunotherapy

Cancer is a major cause of incidence rate and mortality worldwide. In recent years, cancer immunotherapy has made great progress in the preclinical and clinical treatment of advanced malignant tumors. However, cancer patients will have transient cancer suppression reaction and serious immune related...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiyan, Liu, Yulin, Huang, Zihua, Guo, Yajie, Li, Qingjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046726/
https://www.ncbi.nlm.nih.gov/pubmed/35497343
http://dx.doi.org/10.3389/fbioe.2022.878524

Ejemplares similares